The role of innate immunity in asthma: leads and lessons from mouse models
20. | Schröder, N. W. J. and Maurer, M.: The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 2007: 62; 579-590. IF: 5.01 |
Found 534 hits.
20. | Schröder, N. W. J. and Maurer, M.: The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 2007: 62; 579-590. IF: 5.01 |
160. | Rongisch, R., Schmidt, E., Deresz, N., Deresz, K., Schöfer, H., Just-Nübling, G., Schäkel, K., Jakob, T., Maurer, M., Sticherling, M., Sunderkötter, C., Babilas, P., Spornraft-Ragaller, P., Traidl-Hoffmann, C., Gläser, R., Hartmann, K., Kolb-Mäurer, A., Wenzel, J., Biedermann, T., Homey, B., Pfützner, W., Weid, F., Fischer, M., Linder, R., and von Stebut, E.+: Travel-associated infectious skin diseases. J. Dtsch. Dermatol. Ges. 2020: 18; 730-733. IF: 5.58 |
r.160
265 | Weller, K.+, Maurer, M. Fridman, M., Supina, D., Schranz, J., and Magerl, M.: Health-related quality of life in hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase. Allergy Asthma Proc. 2017: 38; 143-151. IF: 2.21 |
262 | Weller, K.+, Magerl, M., Peveling-Oberhag, A., Martus, P., Staubach, P., and Maurer, M.: The angioedema quality of life questionnaire (AE-QoL) – assessment of sensitivity to change and minimal clinically important difference. Allergy 2016: 71; 1203-1209. IF: 7.36 |
50 | Siebenhaar, F., Sharov, A. A., Peters, E. M. J., Sharova, T. Y., Syska, W., Mardaryev, A. N., Freyschmidt-Paul, P., Sundberg, J. P., Maurer, M. and Botchkarev, V. A.+: Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (Alopecia Areata). J. Invest. Dermatol. 2007: 127; 1489-1497. IF: 4.83 |
52. | Maurer, M., Weller, K., Bindslev-Jensen, C., Giménez-Arnau, A., Bousquet, P., Bousquet, J., Canonica, G. W., Church, M. K., Godse, K. V., Grattan, C. E. J., Greaves, M. W., Hide, M., Kalogeromitros, D., Kaplan, A. P., Saini, S. S., Zhu, X. J., and Zuberbier, T.: Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy 2011: 66; 317-330. IF: 6.27 |
r.052
197 | Rogala, B., Bozek, A.+, Glück, J., Rymarczyk, B., Jarzab, J., and Maurer, M.: Coexistence of angioedema alone with impaired glucose tolerance. Int. Arch. Allergy Immunol. 2014: 165; 265-269. IF: 2.67 |
o.197
126. | Kolkhir, P., Metz, M., Altrichter, S., and Maurer, M.+: Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: a systematic review. Allergy 2017: 72; 1440-1460. IF: 6.05 |
211. |
Kolkhir, P.+, Altrichter, S., Badloe, F. M., Belasn, H., Charles, N., De Vriese, S., Gutermuth, J., Huygen, L., Kocatürk, E., Kortekaas Krohn, I., Muñoz, M., Moñino-Romero, S., Reber, L. L., Scheffel, J., Steinert, C., Xiang, Y.-K., and Maurer, M.: The European network for IgE-mediated autoimmunity and autoallergy (ENIGMA) initiative. Nat. Med. 2024: 30; 920-922. IF: TBD (IF 2023: 58.70) |
r.211
212. |
Elieh-Ali-Komi, D., Bot, I., RodrÃguez-González, M., and Maurer, M.+: Cellular and molecular mechanisms of mast cells in atherosclerotic plaque progression and destabilization. Clin. Rev. Allergy Immunol. 2024: 66; 30-49. IF: TBD (IF 2023: 8.40) |
r.212